WallStreetZenWallStreetZen

NYSEMKT: NRXS
Neuraxis Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Neuraxis earnings were -$8.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest NRXS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.7M, down 5.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NRXS reported annual earnings of -$8.5M, with -42.2% growth.

NRXS earnings history

Current Revenue
$2.7M
Current Earnings
-$8.5M
Current Profit Margin
-314.7%

NRXS Return on Equity

Current Company
N/A
Current Industry
-2%
Current Market
34.1%

NRXS undefined

Current Company
-356.7%
Current Industry
-0.4%
NRXS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NRXS announces earnings.

NRXS undefined

Current Company
-347.09%
Current Industry
5.9%
NRXS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRXS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NRXS-$8.00M-$8.45MN/A-$1.22
GOVX-$24.88M-$24.99MN/A-$4.82
CHRO-$7.17M-$7.96MN/A-$1.43
PSTV-$8.40M-$12.98MN/A-$1.95
NERV$1.46M$1.44M-16.98%$0.19
View Top Biotech Stocks

Neuraxis Earnings Reports & History FAQ

What were Neuraxis's earnings last quarter?

Neuraxis (NYSEMKT: NRXS) reported Q4 2024 earnings per share (EPS) of -$0.21, up 134.43% year over year. Total NRXS earnings for the quarter were -$1.66 million. In the same quarter last year, Neuraxis's earnings per share (EPS) was $0.61.

If you're new to stock investing, here's how to buy Neuraxis stock.

Is Neuraxis profitable or losing money?

As of the last Neuraxis earnings report, Neuraxis is currently losing money. Neuraxis's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$8.24 million, a 43.65% decrease year over year.

What was NRXS's earnings growth in the past year?

As of Neuraxis's earnings date in Q2 2025, Neuraxis's earnings has grown year over year. NRXS earnings in the past year totalled -$8.45 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.